ThermoGenesis has filed a notice of an exempt offering of securities to raise $3,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, ThermoGenesis is raising $3,000,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Jeffery Cauble played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About ThermoGenesis
ThermoGenesis Holdings, Inc. is an industry leader in the development and commercialization of automated cell processing technologies for the cell and gene therapy fields. We offer a full suite of solutions for automated clinical biobanking, point-of-care applications, and large scale cellular processing and manufacturing for the emerging CAR-T immunotherapy market.
To learn more about ThermoGenesis, visit http://www.thermogenesis.com/
Contact:
Jeffery Cauble, Chief Financial Officer
916-858-5100
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.